Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Human Pathology|May 1, 1994
Frequency and distribution of numerical chromosomal aberrations in prostatic cancerR P Henke, E Krüger, N Ayhan, et al.
Der Urologe. Ausg. A|May 1, 1998
[Development of tumor selection based on pathological stage in clinically localized prostate carcinoma]J Noldus, M Graefen, P Hammerer, et al.
Anticancer Research|May 1, 2001
The expression of angiopoietins and their receptor Tie-2 in human prostate carcinomaJ H Wurmbach, P Hammerer, S Sevinc, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1993
Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kineticsR P Henke, E Krüger, N Ayhan, et al.
The International Journal of Biological Markers|November 1, 2002
The impact of intraoperative manipulation of the prostate on total and free prostate-specific antigenF Oberpenning, H-P Schmid, W Fuchs-Surdel, et al.
Anticancer Research|September 2, 1999
The biologic lower detection limit of six ultrasensitive PSA assaysR Junker, B Brandt, A Semjonow, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 5, 2008
[Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR]H Schmidt, A Semjonow, K Csiszar, et al.
Urology|December 1, 1996
Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigenA Semjonow, F Oberpenning, B Brandt, et al.
Der Urologe. Ausg. A|May 1, 1998
[Plasma TGF-beta1 concentrations in patients with prostate carcinoma or benign prostatic hyperplasia]I Lange, P Hammerer, C Knabbe, et al.
The Journal of Urology|November 20, 1997
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasiaA Haese, M Graefen, J Noldus, et al.
Pageof 11